GeoWealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

GeoWealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,478	Closed	-$1.01M	–	406
2021 Q2	$1.01M	Buy	7,478 +656	+10%	+$86.2K	0.13%	101
2021 Q1	$925K	Buy	6,822 +738	+12%	+$110K	0.14%	87
2020 Q4	$856K	Buy	6,084 +3,165	+108%	+$405K	0.14%	114
2020 Q3	$323K	Buy	+2,919	New	+$327K	0.1%	116
2019 Q4	–	Sell	-3,442	Closed	-$262K	–	231
2019 Q3	$262K	Buy	+3,442	New	+$286K	0.06%	169

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

GeoWealth Management's XBI Position: Q3 2021 in Review

GeoWealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2021, closing a stake of 7,478 shares — an estimated $1.01M sold.

GeoWealth Management first reported a position in XBI in Q3 2019 and held it in 5 quarters. The position peaked at $1.01M in Q2 2021. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

GeoWealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2021 after selling out during the quarter.
GeoWealth Management sold 7,478 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $1.01M.
GeoWealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and held it in 5 quarters.
GeoWealth Management's State Street SPDR S&P Biotech ETF position peaked at $1.01M in Q2 2021.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on GeoWealth Management's 13F filing for Q3 2021, filed 12 Nov 2021.